Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders ClinicJNNP 84:130-135, Pondal, M.,et al, 2013
Neurotoxicity of Commonly Used Antineoplastic AgentsNEJM 291:75, 1271974., Weiss,H.,et al, 1974